Interpretation of subjective symptoms in double-blind placebo-controlled food challenges - interobserver reliability

Allergy ◽  
2004 ◽  
Vol 59 (3) ◽  
pp. 354-356 ◽  
Author(s):  
M. Gellerstedt ◽  
J. Magnusson ◽  
U. Grajo ◽  
S. Ahlstedt ◽  
U. Bengtsson
Keyword(s):  
Interobserver Reliability ◽  
Subjective Symptoms ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Food Challenges

Adverse reactions to foods in adulthood assessed by double-blind placebo-controlled food challenges

2002 ◽  
Vol 109 (1) ◽  
pp. S92-S92 ◽  
Author(s):  
Julia Rodriguez ◽  
Gemma Izquierdo ◽  
Paloma Poza-Guedes ◽  
Paloma Campo ◽  
Pilar Daroca ◽  
...  
Keyword(s):  
Adverse Reactions ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Food Challenges

scholarly journals Pitfalls in double-blind, placebo-controlled oral food challenges

Allergy ◽  
2007 ◽  
Vol 62 (7) ◽  
pp. 729-732 ◽  
Author(s):  
B. Niggemann ◽  
K. Beyer
Keyword(s):  
Double Blind ◽  
Double Blind Placebo ◽  
Food Challenges

New validated recipes for double-blind placebo-controlled low-dose food challenges

2013 ◽  
Vol 24 (3) ◽  
pp. 282-287 ◽  
Author(s):  
Anna Winberg ◽  
Lisbeth Nordström ◽  
Åsa Strinnholm ◽  
Annica Nylander ◽  
Anette Jonsäll ◽  
...  
Keyword(s):  
Low Dose ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Food Challenges

scholarly journals Tolerance to low-digestible carbohydrates: symptomatology and methods

2001 ◽  
Vol 85 (S1) ◽  
pp. S17-S21 ◽  
Author(s):  
Philippe Marteau ◽  
Bernard Flourié
Keyword(s):  
Small Intestine ◽  
Breath Test ◽  
Absorption Capacity ◽  
Subjective Symptoms ◽  
Intersubject Variability ◽  
Intrasubject Variability ◽  
Hydrogen Breath Test ◽  
Experimental Conditions ◽  
Double Blind ◽  
Double Blind Placebo

Low-digestible carbohydrates (LDCs) are incompletely or not absorbed in the small bowel and fermented in the colon. They are usually well tolerated but may also have some dose-related undesirable effects due to their natural osmotic potential and/or excessive fermentation: borborygmi, excessive flatus, bloating, abdominal cramps and eventually diarrhoea. There is an important intersubject variability in the tolerance to LDCs because of differences in absorption capacity, motility pattern, colonic response and intestinal sensitivity. There is also a great intrasubject variability, depending on the type of LDC, dosage and type of consumption. Absorption of LDC in the small intestine can be assessed using hydrogen breath test or intubation techniques or analysis of ileostomy effluents. Double-blind, placebo-controlled studies are required to assess the subjective symptoms of intolerance, and the experimental conditions may influence the results.

Published recipes for double-blind placebo-controlled food challenges

Allergy ◽  
2005 ◽  
Vol 60 (9) ◽  
pp. 1212-1212 ◽  
Author(s):  
Berber Vlieg-Boerstra ◽  
Anthony Dubois
Keyword(s):  
Double Blind ◽  
Double Blind Placebo ◽  
Food Challenges
Sign in / Sign up

Export Citation Format

Share Document